J Liver Cancer Search


Journal of the Korean Liver Cancer Study Group 2010;10(1):69-72.
Published online June 30, 2010.
A case of hepatocellular carcinoma presented with bone metastasis
EJ Kang, SW Jeong, JY Jang, SH Lee, SG Kim, YK Chun, YS Kim, YD Cho, HS Kim, BS Kim
Institute for Digestive Research, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea
Correspondence:  SW Jeong,
Email: eongsw@hosp.sch.ac.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide in terms of incidence. The majority of tumors are diagnosed when advanced. The long-term prognosis of HCC remains poor, with a 5-year survival rate of <5%. However, recent progress in the treatment of HCC has made it possible for the patient to survive longer, and as a result, distant metastasis from HCC, including bone metastasis has increased and attracted more attention than before. Of the various metastatic sites, the most common site is the lungs, followed by the lymph nodes and bone. The most frequent sites of bone metastasis are the spine, pelvis and rib in that order. Single bone lesion was associated with a favorable outcome, while multiple bone lesions may be associated with severe pain and increasing rate of leucopenia, anemia, and thrombocytopenia, sometimes making radiotherapy administration difficult. The incidence of bone metastasis in HCC is low. Moreover HCC diagnosed with bone metastasis is very rare. We report a patient who present with bone metastasis before the diagnosis of a primary cancer.
Key Words: Hepatocellular carcinoma; Bone metastasis

Editorial Office
1521 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next